Goethe University

This study tests a drug called isatuximab in 40 adults with a type of leukemia (T-ALL) that has come back or not responded to standard treatment. The drug targets a protein on the cancer cells to help the body fight the disease. The goal is to see if it can reduce or eliminate th…

This study tests whether a type of brain stimulation called TMS can reduce cravings for alcohol in people with alcohol addiction. 34 adults will receive TMS sessions daily for 5 days, and researchers will measure changes in cravings, heart rate, and brain activity. The goal is to…

This study is observing 100 adults with major depression who are already receiving transcranial magnetic stimulation (TMS) as part of their regular care. Researchers want to see if brain scans and symptom changes can predict who responds best to TMS. Participants will have MRI sc…

This study watches 60 people who are having their bladder removed with robot-assisted surgery. Researchers want to see how much blood is lost, how much pain people feel, and how many need blood transfusions. The goal is to gather information, not to test a new treatment.

This study is a large registry that gathers medical information and biological samples from 10,000 adults with acute lymphoblastic leukemia (ALL) and similar blood cancers. The goal is to track how patients are diagnosed, treated, and how they fare over time, helping doctors impr…

This study tests whether a natural supplement called urolithin A (MitoPure®) can improve the immune response in people with solid tumors like lung cancer or melanoma who are starting standard immunotherapy. About 45 participants will be randomly assigned to take either the supple…